Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...
CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the init...
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and B...
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and ...
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the Nationa...
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinic...
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical...
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...
